Home  > 
  Intec Pharma begins phase i trial of Accordion Pill for cannabinoid therapies,   March 24, 2017
  OncoSec presents data on "Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology" at Keystone Symposia Conference,   March 23, 2017
  Novartis phase III RELAX-AHF-2 study of serelaxin in AHF patients fails to meet primary endpoints,   March 23, 2017
  WntResearch reports positive results from phase 1b study of drug candidate Foxy-5,   March 22, 2017
  Blueprint Medicines begins phase 1 trial of RET inhibitor, BLU-667 to treat patients with NSCLC, MTC and advanced solid tumors,   March 22, 2017
  Novartis presents positive data from IL-17A inhibitor, Cosentyx at 3th Annual Maui Derm for Dermatologists 2017,   March 21, 2017
  Sonoma Pharma announces positive results from SebuDerm gel study to treat Seborrheic Dermatitis,   March 21, 2017
  Astrazeneca’s CVD-REAL study data indicates treatment with SGLT-2 inhibitors reduces heart failure compared to T2D medicines,   March 21, 2017
  Amgen announces study on PCSK9 inhibitor prescription rejection rates demonstrate significant access barriers for appropriate patients,   March 21, 2017
  Abbott’s MitraClip system shows favorable outcome in treating people with Mitral Regurgitation,   March 21, 2017
  Eli Lilly phase 3 MONARCH 2 breast cancer study of abemaciclib meets primary endpoint,   March 21, 2017
  Janssen’s phase 3 study finds Xarelto superior to aspirin for long-term prevention of recurrent blood clots in patients with VTE,   March 20, 2017
  Amgen reports results from Repatha cognitive function trial evaluating impact on cognitive function,   March 20, 2017
  Novartis Entresto improves glycemic control in reduced ejection fraction heart failure patients with diabetes,   March 20, 2017
  Seres Therapeutics to initiate new SER-109 phase 2 study in patients with multiply recurrent C. Difficile infection,   March 20, 2017
  Pharnext initiates phase 3 extension study PLEO-CMT-FU of PXT3003 to treat charcot-marie-tooth disease Type 1A,   March 20, 2017
  Oncolytics Biotech collaborates with Myeloma UK & Celgene using Reolysin in combo with Imnovid/Revlimid in patients with myeloma,   March 18, 2017
  Nordic Nanovector begins phase 1 study evaluating Betalutin in patients with relapsed diffuse large B-cell lymphoma,   March 18, 2017
  Longeveron completes enrollment of patients in first phase of LMSCs clinical trial to Alzheimer's disease,   March 17, 2017
  Jazz Pharmaceuticals enrolls first patient in phase 3 clinical study of JZP-258 to treat adult narcolepsy patients,   March 17, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |